Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 11847721

Complementary healthcare practices.

L A Giese
View original source ↗Export metadata ↓

Abstract

This column provides a brief overview of the historical use of herbs for hepatobiliary disease. It includes information regarding both the harmful and helpful effects of herbs on the hepatobiliary system. Certainly more research is needed. Studies are currently in progress, many funded by grants from various agencies including the National Institute of Health. Since one-third of patients attending liver clinics are using these potentially helpful or harmful herbs, it is an important issue for gastroenterology nurses, associates, and other health care providers to address. We must increase our knowledge, advocate for safety and research, and discuss the use of herbs in a non-judgmental, informed manner.

Explore related subjects

Anti-Infective AgentsBiliary Tract DiseasesGlycyrrhizic AcidHumansLiver DiseasesSilybum marianumPhytotherapyPlant PreparationsJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L A Giese. Complementary healthcare practices.. https://doi.org/10.1097/00001610-200101000-00010

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Comparative antimicrobial activities of gatifloxacin, sitafloxacin and levofloxacin against Mycobacterium tuberculosis replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.

Mycobacterium tuberculosis (MTB) is capable of invading not only macrophages (Mphis) but also type II pneumocytes. In this study, we compared the antimicrobial activities of fluoroquinolones, including gatifloxacin, sitafloxacin and levofloxacin, against the MTB replication in the Mono Mac 6 human Mphi cell line (MM6-Mphis) and the A-549 human type II alveolar epithelial cell line (A-549 cells). When test quinolones were added at the MIC (0.125, 0.06 and 0.25 mg/l for gatifloxacin, sitafloxacin and levofloxacin, respectively) to the culture media of MTB-infected cells, these drugs exerted growth-inhibitory activity against intracellular organisms in the order of sitafloxacin > gatifloxacin > levofloxacin. On the other hand, when test quinolones were added at Cmax in the blood (1.7, 1.0 and 2.0 mg/l for gatifloxacin, sitafloxacin and levofloxacin, respectively), these drugs exhibited bactericidal activity against intracellular MTB in the order of gatifloxacin > sitafloxacin > or = levofloxacin. In addition, when test drugs were added at 1/8 C(max) to 1/2 C(max), the efficacy was in the order of sitafloxacin > gatifloxacin > levofloxacin. Thus, it appears that the MIC values of fluoroquinolones are not always predictive of their antimicrobial activity against intracellular MTB. In this context, it was also found that intracellular uptake of these quinolones by MM6-Mphis and A-549 cells was in the order of sitafloxacin > gatifloxacin > levofloxacin. This implies that the cellular permeability of these quinolones is an important factor that determines their efficacy to eliminate intracellular MTB organisms.

Anti-Infective Agents↗
PubMed2003

Photoelectron spectra of important drug molecules: zidovudine and artemisinine.

The electronic structures of the anti-HIV drug zidovudine (AZT) and antimalarial drug artemisinine have been investigated by UV photoelectron spectroscopy (UPS), MO calculations, and comparison with the spectra of related molecules. The analysis of their electronic structure is correlated with known biological activities.

Anti-Infective Agents↗